Fentanyl and clonidine

PreclinicalSmall molecule

RRegion Skane

Fentanyl and clonidine is one of 6 small molecule programs targeting Hypothermia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HypothermiaActive, not recruiting

HypothermiaPreclinical

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Hypothermia

#DrugCompanyPhaseTrials

Bridion

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Approved

1 2

Amikin

IInsmed Incorporated

Preclinical

1 3

Anerem

AAcacia Pharma Ltd

Preclinical

1 4

Xarelto

WWim Janssens

Preclinical

1 5

Duragesic

CCephalon

Preclinical

1 6

Fentanyl and clonidine

RRegion Skane

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hypothermia1 trial

Fentanyl and Clonidine for Analgesia During Hypothermia in Term Asphyxiated Infants

Completed·RRegion Skane··NCT03177980·49 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Fentanyl and clonidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fentanyl and clonidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fentanyl and clonidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Region Skane company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: RRegion Skane

Fentanyl and clonidine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hypothermia1 trial

References

Drug Info

Quick Facts

Related News